Segmentation by application and analysis of women’ s health market covers Postmenopausal osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, Polycystic ovary syndrome( PCOS). Endometriosis is a problem affecting a woman’ s uterus; the place where a baby grows when a woman is pregnant. The misplaced tissue can cause pain, infertility, and very heavy periods. Polycystic ovary syndrome happens when a woman’ s ovaries or adrenal glands produce more male hormones than normal.
Women with PCOS are at higher risk of developing diabetes and heart disease. Women who can get pregnant but unable to stay pregnant is also considered as infertile. About 10 %( 6.1 million) of women in United States aged 15-44 years have difficulty getting pregnant or staying pregnant. A woman has reached menopause when she has not had a period for 12 months in a row( 45-55 age). Menopause happens because the woman’ s ovary stops producing the hormones estrogen and progesterone.
Contraception is a method of birth control available to prevent unintended pregnancy. Osteoporosis is of major concern among post-menopausal women and this disease is projected to affect around 20 percent of postmenopausal women. The disease is characterized by substantial loss of bone mass and increasing the risk of serious fractures. Currently the menopause therapeutics market is determined by hormone therapeutics. In 2015, the postmenopausal osteoporosis segment conquered the market and accounted for more than 37 % of the market share.
Browse Full Research Report @ https:// www. millioninsights. com / industry-reports / womens-health-market
Market size by drug class includes Evista, Xgeva, Mirena, Zometa, Minastrin 24FE, Nuvaring, Forteo, Premarin, Actonel, Ortho-Tri-Cy LO 28, and Reclast. On the basis of geography, women’ s health therapeutics market size comprises four major regions: North America, Europe, Asia Pacific, and Rest of the World. North America and Europe are the foremost markets for women health therapeutics. This is because of increased awareness regarding women health. Contraception and fertility control are supported by the governments of developing countries such as India and China to curb the growing population. This trend is expected to show positive growth of women’ s health market from 2014 to 2025. The key players of women’ s health market are Allergan, Bayer Healthcare, Merck, Pfizer, Teva Pharmaceuticals, Agile Therapeutics, Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, Ferring International Center.
Market Segmentation
Application of Women’ s Health Outlook( Revenue, USD Million, 2014- 2025)
• Postmenopausal Osteoporosis
• Infertility